1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice
2007

CDIM9 Inhibits Growth of Basal-Like Breast Cancer

Sample size: 13 publication 10 minutes Evidence: moderate

Author Information

Author(s): Su Yunpeng, Vanderlaag Kathryn, Ireland Courtney, Ortiz Janelle, Grage Henry, Safe Stephen, Frankel Arthur E

Primary Institution: Scott & White Cancer Research Institute

Hypothesis

The study investigates the anti-basal-like breast tumor activity of CDIM9 in vitro and in vivo.

Conclusion

CDIM9 showed potent antiproliferative effects on basal-like breast cancer cells in tissue culture and significant growth inhibition in animal models at safe doses.

Supporting Evidence

  • CDIM9 inhibited the growth of MDA-MB231 tumor xenografts by 87%.
  • 46% of treated mice had complete durable remissions.
  • CDIM9 treatment resulted in a mean tumor growth inhibition of 67%.

Takeaway

CDIM9 is a new drug that helps stop the growth of a type of breast cancer called basal-like breast cancer, and it worked well in mice.

Methodology

The study used in vitro cell lines and in vivo mouse models to assess the effects of CDIM9 on breast cancer growth.

Limitations

The study primarily focused on animal models, and the effects in humans are yet to be determined.

Participant Demographics

The study involved athymic nude mice, which are commonly used in cancer research.

Statistical Information

P-Value

0.009

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1761

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication